The newly published market report titled Liquid Biopsy Market analysis offers a robust, data-centric perspective on how the Liquid Biopsy industry has evolved and where it is headed through 2035. Built on credible, verified insights, the study delivers a structured review of market size, geographic expansion, and strategic behavior across stakeholders.
I recently came across a report by Roots Analysis that really put things into perspective. According to them, The global liquid biopsy market size is valued at USD 7.0 billion in 2025, is project to reach USD 8.1 billion in 2026 and USD 29.8 billion by 2035, representing a higher CAGR of 15.6% during the forecast period 2026 to 2035.
The research highlights general factors that may be contributing to market expansion, offering a neutral and data-focused view. The Liquid Biopsy Market forecast is based on the analysis of available information, without assigning speculative cause-and-effect reasoning to specific trends.
Report Highlights
Key Questions Answered
- Question 1: What is liquid biopsy?
- Question 2: What is the market size of liquid biopsy?
- Question 3: Which region holds the largest market share in the liquid biopsy market?
- Question 4: How big is the liquid biopsy market?
- Question 5: What is the likely growth rate (CAGR) of liquid biopsy market?
- Question 6: What are the leading market segments in the liquid biopsy market?
Full Report: https://www.rootsanalysis.com/reports/liquid-biopsy-and-nicd-market/279.html
- Key Report Attributes
- Historical Trend
- Forecast Period
- Market Size 2026
- Market Size 2035
- CAGR (Till 2035)
- Application
- Type of Target Disease Indication
- Type of Circulating Biomarker
- Type of Sample
- End User
- Key Geographical Regions
- Key Players
- Customization Scope
- PowerPoint Presentation(Complimentary)
- Excel Data Packs(Complimentary)
Regional Analysis:
North America, Europe, Asia-Pacific, Rest of the World
Company Review: Top players include Amoy Diagnostics, ArcherDX, Biocartis, Cell Search, CellMax Life, Datar Cancer Genetics, DiaCarta, EONE-DIAGNOMICS, Exosome Diagnostics, GeneCast Biotechnology, Integrated DNA Technologies, Lucence, MDNA Life Sciences, Miltenyi Biotec, NeoGenomics, ONCODE Scientific, OncoDNA, QIAGEN, PANAGENE, Personal Genome Diagnostics, Predicin, ScreenCell, Tecan, Thermo Fisher Scientific. Each profile examines regional strategy, manufacturing capacity, and product focus.
The research also explores how suppliers, distributors, and end-users engage within the current Liquid Biopsy Market ecosystem, highlighting the operational interplay driving this market forward.
Research Integrity
Report is prepared using a blend of primary interviews, public datasets, and proprietary databases.
Collection of relevant data points to facilitate the process of market estimation.
Integrating micro and macro parameters, which influence the pace of market progression
Analyzing growth opportunities across various market segments
Need a tailored summary or extended breakdown of the data? Reach out to our team for custom insights specific to your business focus.
About Roots Analysis
Roots Analysis is a global research and consulting powerhouse specializing in Healthcare, Pharmaceutical, Biotech, Semiconductors, Chemicals and ICT industry. With over a decade of experience, they’ve supported more than 750 clients — spanning Fortune 500 companies, innovative startups, academic institutions, VCs, and strategic investors.
Why Use Roots Analysis in era of Artificial Intelligence?
Tailored Insights
Robust Methodology
Smart Decisions Made Easy
By combining world-class domain expertise, careful data gathering, and dialogue with senior industry experts, Roots Analysis ensures their deliveries are trustworthy, actionable, and aligned with strategic priorities. The value proposition generated on insights generated by Roots Analysis team is unparalleled in the market research industry.
Services Offered:
Consulting Services (custom insights supporting strategic and tactical requirements, off-the-shelf ready to consume work)
Roots Analysis offers bespoke consulting services tailored to the unique needs of clients in the life sciences and healthcare sectors.
They specialize in market assessments, tracking industry trends, dynamics, and competitive positioning. These insights help companies fine-tune their product strategies and market-entry plans.
Roots Analysis also delivers expert guidance on partnerships, licensing, and investment opportunities. Their strategic support extends to KOL identification, publication analysis, and regulatory intelligence, making them a valuable partner in business growth and innovation.
Subscription Services (bundled services supporting multiple topics and domains for a firm)
With their subscription plans, Roots Analysis provides seamless access to a vast library of market intelligence reports. Subscribers enjoy unlimited downloads in multiple formats.
The service includes on-demand research support—allowing clients to request tailored insights and initiate custom research topics. This ensures that emerging needs are met quickly and effectively.
Each subscription comes with a dedicated account manager and direct access to analysts. Flexible billing options and tiered plans make this service suitable for organizations of all sizes seeking continuous, reliable insights.
Contact Details for Roots Analysis
Chief Executive: Gaurav Chaudhary
Email: Gaurav.chaudhary@rootsanalysis.com
Website: https://www.rootsanalysis.com/
